🇺🇸 Osmotic-release oral system methylphenidate in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Vaginal Haemorrhage — 1 report (100%)
Other Neurology / Psychiatry approved in United States
Frequently asked questions
Is Osmotic-release oral system methylphenidate approved in United States?
Osmotic-release oral system methylphenidate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Osmotic-release oral system methylphenidate in United States?
Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.